Pendulum Therapeutics fetches $54m Series C
Pendulum Therapeutics, a biotech company targeting the microbiome, has secured $54 million in Series C funding.
Pendulum Therapeutics, a biotech company targeting the microbiome, has secured $54 million in Series C funding.
Copyright PEI Media
Not for publication, email or dissemination